1. Home
  2. CPIX vs SQNS Comparison

CPIX vs SQNS Comparison

Compare CPIX & SQNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • SQNS
  • Stock Information
  • Founded
  • CPIX 1999
  • SQNS 2003
  • Country
  • CPIX United States
  • SQNS France
  • Employees
  • CPIX N/A
  • SQNS N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • SQNS Semiconductors
  • Sector
  • CPIX Health Care
  • SQNS Technology
  • Exchange
  • CPIX Nasdaq
  • SQNS Nasdaq
  • Market Cap
  • CPIX 40.1M
  • SQNS 46.5M
  • IPO Year
  • CPIX 2009
  • SQNS 2011
  • Fundamental
  • Price
  • CPIX $3.15
  • SQNS $1.42
  • Analyst Decision
  • CPIX
  • SQNS Strong Buy
  • Analyst Count
  • CPIX 0
  • SQNS 1
  • Target Price
  • CPIX N/A
  • SQNS $7.50
  • AVG Volume (30 Days)
  • CPIX 110.2K
  • SQNS 1.0M
  • Earning Date
  • CPIX 08-05-2025
  • SQNS 08-22-2025
  • Dividend Yield
  • CPIX N/A
  • SQNS N/A
  • EPS Growth
  • CPIX N/A
  • SQNS N/A
  • EPS
  • CPIX N/A
  • SQNS 2.16
  • Revenue
  • CPIX $41,083,299.00
  • SQNS $38,858,000.00
  • Revenue This Year
  • CPIX N/A
  • SQNS N/A
  • Revenue Next Year
  • CPIX N/A
  • SQNS $93.87
  • P/E Ratio
  • CPIX N/A
  • SQNS $0.66
  • Revenue Growth
  • CPIX 5.82
  • SQNS 40.06
  • 52 Week Low
  • CPIX $1.04
  • SQNS $0.95
  • 52 Week High
  • CPIX $7.25
  • SQNS $4.28
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 37.09
  • SQNS 36.54
  • Support Level
  • CPIX $2.52
  • SQNS $1.40
  • Resistance Level
  • CPIX $3.76
  • SQNS $1.51
  • Average True Range (ATR)
  • CPIX 0.59
  • SQNS 0.20
  • MACD
  • CPIX -0.14
  • SQNS -0.04
  • Stochastic Oscillator
  • CPIX 19.39
  • SQNS 15.89

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About SQNS Sequans Communications S.A.

Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its offer 5G/4G chips and modules fully optimized for non-smartphone devices. The company covers applications such as smart mobility and logistics, smart utility meters, smart cities, smart industries, e-health and wellness, and smart homes to name few. The Company has one operating segment, which is the design and marketing of semiconductor components for cellular wireless systems. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.

Share on Social Networks: